CheckMyRecalls

Eugia US LLC recalls Gentamicin Injection

Published
25 Jun 2025
Units affected
48,000 vials
Agency
FDA
Country
United States

The hazard

Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25

Brand / company
Eugia US LLC
Codes / lots
Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 25 Jun 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.